Doctors pledge to become medical cannabis prescribers at MCCS conferenceNovember 14, 2019 | IN NEWS | BY Kate Thorpe
This week (Wednesday 13 November) we proudly bought together leading Medical Cannabis experts and healthcare professionals to our conference, ‘Medical Cannabis in Practice: Prescribing, practicalities and the patient experience’.
During the event, doctors pledged to become medical cannabis prescribers, to access education and explore and contribute to the evidence base for medical cannabis treatments at our first annual conference in London.
We welcomed attendees from across the sector who were interested in learning more about access to Medical Cannabis in the UK today and the day provided attendees with a practical insight into medical cannabis, discussed the global position of the drug’s evidence, the UK regulatory space, efficacy, research and the impact on patients.
Speakers included one of the industry’s leading experts, Professor David Nutt of DrugScience. He discussed the charity’s newly launched Project Twenty21 trial – Europe’s first and biggest national medical cannabis registry of 20,000 patients, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis.
Professor Mike Barnes provided an introduction to medical cannabis and explored the global evidence and Executive Director Hannah Deacon talked about the frustrations in fighting for access of the drug for her son, Alfie Dingley. Dr Dani Gordon advised delegates on understanding and navigating medical cannabis and CBD treatments.
Dr Liz Iveson, complex care specialist and prescribing doctor shared stories of patients she is successfully treating with medical cannabis and Dr Leon Barron provided insights into the role of the GP in this space.
Professor Mike Barnes, Chair of the UK Medical Cannabis Clinicians Society, said: “We were pleased to welcome clinicians, healthcare and industry professionals to this conference that not only educated attendees on all the latest from the Medical Cannabis sector but provided a call to action for doctors to learn more about the life-changing benefits of this treatment.”
Supporting the conference were CiiTECH Ltd, a cannabis biotech company that focuses on discovering, developing and commercialising cannabinoid products for the global market and the leading Australian medical cannabis manufacturer, Little Green Pharma, who are now supplying the European medical cannabis market.
The MCCS is made up of some of the most respected medical cannabis clinicians in the country and ensure that clinicians have access to evidence, education, training, guidance and support to enable them to prescribe medical cannabis to patients who could benefit from this life-changing treatment.
Thank you to those who attended our conference, keep up to date on our website and social media channels for news of future events, workshops and conferences. You can also sign up to our mailing list to be the first to know more.